Acute Leukemia Guideline v2 Expert Panel

 View Only
last person joined: one year ago 

SITC's Acute Leukemia Immunotherapy Guideline v2 Expert Panel is comprised of leaders in the immuno-oncology field who provide interdisciplinary perspectives including medical oncology, community oncology, radiation oncology, surgery, pathology, and nursing as well as other specializations, as necessary, and at least one patient advocate or representative. The Expert Panel draws from their own practical experience as well as evidence in the published literature and clinical trial data to develop the evidence- and consensus-based recommendations that are published in SITC's clinical practice guideline.

Chair

Naval Daver, MD
University of Texas MD Anderson Cancer Center


Chair

Nirali N. Shah, MD
National Institutes of Health